Experimental chemotherapy with Allium sativum (Liliaceae) methanolic extract in rodents infected with Leishmania major and Leishmania donovani

Journal of Vector Borne Diseases

Volumn 47, Issue 3, 2010, Pages 160-167

  Wabwoba, Byrum W ^a   Anjili, Christopher O ^b   Ngeiywa, Moses M ^c   Ngure, Peter K ^d   Kigondu, Elizabeth M ^b   Ingonga, Johnstone ^b   Makwali, Judith ^c  

^a Department of Applied Sciences   (Kenya)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c MOI UNIVERSITY   (Kenya)

^d DAYSTAR UNIVERSITY   (Kenya)

Author keywords

Amastigotes and promastigotes; Antimonials; Leishmaniasis; Methanolic extract

Indexed keywords

AMPHOTERICIN B; GARLIC EXTRACT; METHANOL; NITRIC OXIDE; STIBOGLUCONATE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROTOZOAL ACTIVITY; ARTICLE; BAGG ALBINO MOUSE; BODY WEIGHT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; IN VITRO STUDY; IN VIVO STUDY; LEISHMANIA DONOVANI; LEISHMANIA MAJOR; LEISHMANIASIS; MOUSE; NONHUMAN; SYRIAN HAMSTER; TREATMENT RESPONSE; VERO CELL;

ANIMALS; ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; CERCOPITHECUS AETHIOPS; CRICETINAE; DISEASE MODELS, ANIMAL; GARLIC; HUMANS; LEISHMANIA DONOVANI; LEISHMANIA MAJOR; LEISHMANIASIS; MESOCRICETUS; METHANOL; MICE; MICE, INBRED BALB C; PLANT EXTRACTS; VERO CELLS;

EID: 77957340548     PISSN: 09729062     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Tahir AE, Ibrahim AM, Satti GM, Theander TG, Kharazmi A, Khalid SA. The potential antileishmanial activity of some Sudanese medicinal plants. Phytotherapy Res 1998; 12: 576-579.
2. Handman E. Leishmaniasis: current status of vaccine development. Clin Microbiol Rev 2001; 14: 229-243.
3. Santos DO, Coutinho CER, Madeira MF, Bottino CG, Vieira RT, Nascimento SB, et al. Leishmaniasis treatment- a challenge that remains: a review. Parasitol Res 2008; 103: 1-10.
4. Ashford RW. The leishmaniases as emerging and reemerging zoonoses. Internatl J Parasitol 2000; 30: 1269-1281.
5. Patz JA, Graczyk TK, Geller N, Vittor AY. Effects of environmental change on emerging parasitic diseases. International J Parasitol 2000; 30: 1395-1405.
6. Davies CR, Kaye P, Croft SL, Sundar S. Leishmaniasis: new approaches to disease control. British Med J 2003; 326: 377-382.
7. Reithinger R, Brookerb S, Kolaczinski JH. Visceral leishmaniasis in eastern Africa: current status. Trans R Soc Trop Med Hyg 2007; 101: 1169-1170.
8. Berman JD. Chemotherapy of the leishmaniasis: biochemical mechanisms, clinical efficacy and future strategies. Rev Infect Dis 1988; 10: 60-586.
9. Dorland's Illustrated Medical Dictionary. 26 edn. Philadelphia: W.B. Saunders Company 1981; p. 49.
10. Pamplona-Roger GD. Garlic heals and efficiently prevents many diseases. In: Safeliz S.L. editor. Encyclopedia of Medicinal Plants. Madrid, Spain: Education and Health Library 2000; p. 230-243.
11. Mantis AJ, Karaioannoglou G, Spanos GP, Panetsos AG. Food Sci Technol 1978; II: 26-28.
12. Katakura K, Koboyashi, A. Enhancement of infectivity of Leishmania donovani promastigotes by serial mouse passages. J Parasitol 1995; 71(3): 393-394.
13. Hendricks LD, Wright N. Diagnosis of cutaneous leishmaniasis by in vitro cultivation of saline aspirates in Schneider's Drosophila medium. Am J Trop Med Hyg 1979; 28: 962-964.
14. Kimber CD, Evans DA, Robinson BL, Peters W. Control of yeast contamination with 5-fluorocytosin in in vitro cultivation of Leishmania spp. Ann Trop Med Parasitol 1981; 75: 453-454.
15. Wang X, Ge JM, Wang K, Qian J, Zou Y. Evaluation of Emodin-induced cytotoxicity. Assay Drug evelopment Technol 2006; 4: 203-207.
16. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 16: 55-63.
17. Delorenzi JC, Attias M, Gattass CR, Andrade M, Rezende C, Da Cunha Pinto, A, Henriques AT, Bou-Habib DC, Saraiva EM. Anti-leishmanial activity of an indole alkaloid from Peschiera australis. Antimicrobial Agents Chemother 2001; 45: 1349-1354.
18. Berman JD, Lee LS. Activity of antileishmanial agents against amastigotes in human monocyte derived macrophages and in mouse peritoneal macrophages. J Parasitol 1984; 70: 220-225.
19. Hollzmuller P, Sereno D, Cavalevra M, Mangot L, Dauloude S, Vincendeau P, Lemesre JL. Nitric oxidemediated proteasome-dependent oligonucleosomal DNA fragmentation in L. amazonensis amastigotes. Infect Immun 2002; 70: 3727-3735.
20. Chulay JD, Bryceson ADM. Quantification of amasigotes in smears of splenic aspirates from patients with Visceral leishmaniasis. Am J Trop Med Hyg 1983; 323: 475-479.
21. Bradley DJ, Kirkley J. Regulation of Leishmania populations within the host. The variable course of Leishmania donovani infections in mice. Clin Exp Immunol 1977; 30: 119-129.
22. Calixto JB. Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). Braz J Med Biol Res 2000; 33: 179-189.
23. Rates SMK. Plants as a source of drugs. Toxicon 2001; 39: 603-613.
24. Ngure PK, Tonui WK, Ingonga J, Kigondu E, Ng'ang'a Z, Kimutai A. In vitro antileishmanial activity of extracts of Waburgia ugandensis (Canellaceae): a Kenyan medicinal plant. J Medicinal Plants Res 2009; 3(2): 61-66.
25. Dutta A, Mandal G, Mandal C, Chatterjee M. In vitro antileishmanial activity of Aloe vera leaf exudates: A potential herbal therapy in leishmaniasis. Glycoconjugate J 2007; 24: 81-86.
26. Gamboa-Leon MR, Aranda-Gonzalez I, Mut-Martin M, Garcia-Miss MR, Dumonteil E. In vivo and in vitro control of Leishmania mexicana due to garlic-induced NO production. Scandinavian J Immunol 2007; 66: 508-514.